(ADS) adidas - Overview
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE000A1EWWW0
Stock: Footwear, Apparel, Accessories, Outdoor Gear
Total Rating 37
Risk 77
Buy Signal -0.82
| Risk 5d forecast | |
|---|---|
| Volatility | 31.8% |
| Relative Tail Risk | -8.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.23 |
| Alpha | -46.67 |
| Character TTM | |
|---|---|
| Beta | 0.467 |
| Beta Downside | 0.921 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.41% |
| CAGR/Max DD | 0.02 |
EPS (Earnings per Share)
Revenue
Description: ADS adidas February 28, 2026
adidas AG (XETRA: ADS) designs, develops, produces, and markets athletic and sports-lifestyle footwear, apparel, and accessories across Europe, Greater China, Japan, South Korea, Latin America, North America, and other regions. Its portfolio includes the core adidas brand, adidas Golf, and Five Ten outdoor footwear, sold via company-owned stores, franchise locations, shop-in-shops, joint-venture partners, wholesale, and e-commerce channels.
Key recent metrics show adidas generating €23.5 billion in FY 2025 revenue, a 7 % YoY increase driven largely by a 15 % rise in digital sales and a 9 % uplift in North-American direct-to-consumer (DTC) channels. Gross margin expanded to 48.2 % as the firm trimmed inventory to a 3.8-month supply and benefited from favorable Euro-to-Dollar exchange movements. The company’s sustainability agenda-targeting 30 % recycled content in products by 2027-continues to resonate with consumers, supporting a sector-wide shift toward eco-friendly athleisure.
For deeper valuation insights, you might explore ValueRay’s analysis.
Headlines to watch out for
- Global consumer spending on athletic wear impacts revenue
- Supply chain disruptions increase production costs
- Brand perception and marketing effectiveness drive sales
- Competition from Nike and Puma affects market share
- Greater China market performance significantly influences growth
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 1.34b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -10.30 > 1.0 |
| NWC/Revenue: 11.62% < 20% (prev 9.76%; Δ 1.86% < -1%) |
| CFO/TA 0.03 > 3% & CFO 677.0m > Net Income 1.34b |
| Net Debt (3.94b) to EBITDA (3.25b): 1.21 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (178.7m) vs 12m ago 0.06% < -2% |
| Gross Margin: 51.61% > 18% (prev 0.51%; Δ 5110 % > 0.5%) |
| Asset Turnover: 121.3% > 50% (prev 114.7%; Δ 6.61% > 0%) |
| Interest Coverage Ratio: 6.72 > 6 (EBITDA TTM 3.25b / Interest Expense TTM 311.0m) |
Altman Z'' 2.87
| A: 0.14 (Total Current Assets 11.98b - Total Current Liabilities 9.09b) / Total Assets 20.26b |
| B: 0.28 (Retained Earnings 5.76b / Total Assets 20.26b) |
| C: 0.10 (EBIT TTM 2.09b / Avg Total Assets 20.46b) |
| D: 0.31 (Book Value of Equity 4.40b / Total Liabilities 14.14b) |
| Altman-Z'' Score: 2.87 = A |
Beneish M -2.81
| DSRI: 1.21 (Receivables 3.45b/2.71b, Revenue 24.81b/23.68b) |
| GMI: 0.98 (GM 51.61% / 50.77%) |
| AQI: 0.98 (AQ_t 0.18 / AQ_t-1 0.19) |
| SGI: 1.05 (Revenue 24.81b / 23.68b) |
| TATA: 0.03 (NI 1.34b - CFO 677.0m) / TA 20.26b) |
| Beneish M-Score: -2.81 (Cap -4..+1) = A |
What is the price of ADS shares?
As of March 11, 2026, the stock is trading at EUR 141.85 with a total of 984,871 shares traded.
Over the past week, the price has changed by -3.57%, over one month by -9.01%, over three months by -12.11% and over the past year by -36.88%.
Over the past week, the price has changed by -3.57%, over one month by -9.01%, over three months by -12.11% and over the past year by -36.88%.
Is ADS a buy, sell or hold?
adidas has no consensus analysts rating.
What are the forecasts/targets for the ADS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 205.2 | 44.7% |
| Analysts Target Price | - | - |
ADS Fundamental Data Overview March 07, 2026
Market Cap USD = 29.83b (25.91b EUR * 1.1513 EUR.USD)
P/E Trailing = 21.4012
P/E Forward = 14.3472
P/S = 1.0442
P/B = 4.4426
P/EG = 0.5644
Revenue TTM = 24.81b EUR
EBIT TTM = 2.09b EUR
EBITDA TTM = 3.25b EUR
Long Term Debt = 1.90b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 1.25b EUR (from shortTermDebt, last quarter)
Debt = 5.55b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.94b EUR (from netDebt column, last quarter)
Enterprise Value = 29.82b EUR (25.91b + Debt 5.55b - CCE 1.64b)
Interest Coverage Ratio = 6.72 (Ebit TTM 2.09b / Interest Expense TTM 311.0m)
EV/FCF = 125.8x (Enterprise Value 29.82b / FCF TTM 237.0m)
FCF Yield = 0.79% (FCF TTM 237.0m / Enterprise Value 29.82b)
FCF Margin = 0.96% (FCF TTM 237.0m / Revenue TTM 24.81b)
Net Margin = 5.40% (Net Income TTM 1.34b / Revenue TTM 24.81b)
Gross Margin = 51.61% ((Revenue TTM 24.81b - Cost of Revenue TTM 12.01b) / Revenue TTM)
Gross Margin QoQ = 50.82% (prev 51.81%)
Tobins Q-Ratio = 1.47 (Enterprise Value 29.82b / Total Assets 20.26b)
Interest Expense / Debt = 1.57% (Interest Expense 87.0m / Debt 5.55b)
Taxrate = 12.50% (12.0m / 96.0m)
NOPAT = 1.83b (EBIT 2.09b * (1 - 12.50%))
Current Ratio = 1.32 (Total Current Assets 11.98b / Total Current Liabilities 9.09b)
Debt / Equity = 0.96 (Debt 5.55b / totalStockholderEquity, last quarter 5.78b)
Debt / EBITDA = 1.21 (Net Debt 3.94b / EBITDA 3.25b)
Debt / FCF = 16.61 (Net Debt 3.94b / FCF TTM 237.0m)
Total Stockholder Equity = 5.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.54% (Net Income 1.34b / Total Assets 20.26b)
RoE = 23.93% (Net Income TTM 1.34b / Total Stockholder Equity 5.60b)
RoCE = 27.89% (EBIT 2.09b / Capital Employed (Equity 5.60b + L.T.Debt 1.90b))
RoIC = 22.53% (NOPAT 1.83b / Invested Capital 8.12b)
WACC = 6.53% (E(25.91b)/V(31.46b) * Re(7.63%) + D(5.55b)/V(31.46b) * Rd(1.57%) * (1-Tc(0.12)))
Discount Rate = 7.63% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.03%
[DCF] Terminal Value 77.46% ; FCFF base≈1.09b ; Y1≈715.7m ; Y5≈326.5m
[DCF] Fair Price = 26.81 (EV 8.72b - Net Debt 3.94b = Equity 4.79b / Shares 178.5m; r=6.53% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 25.00 | EPS CAGR: -28.28% | SUE: -1.98 | # QB: 0
Revenue Correlation: 52.63 | Revenue CAGR: 3.70% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.31 | Chg7d=-0.513 | Chg30d=-0.513 | Revisions Net=-2 | Analysts=7
EPS current Year (2026-12-31): EPS=9.60 | Chg7d=-1.053 | Chg30d=-1.047 | Revisions Net=-2 | Growth EPS=+28.7% | Growth Revenue=+6.2%
EPS next Year (2027-12-31): EPS=12.04 | Chg7d=-0.527 | Chg30d=-0.578 | Revisions Net=-1 | Growth EPS=+22.9% | Growth Revenue=+9.0%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 7.9% - Earnings Yield 4.7%)
[Growth] Growth Spread = +3.6% (Analyst 6.9% - Implied 3.3%)
P/E Trailing = 21.4012
P/E Forward = 14.3472
P/S = 1.0442
P/B = 4.4426
P/EG = 0.5644
Revenue TTM = 24.81b EUR
EBIT TTM = 2.09b EUR
EBITDA TTM = 3.25b EUR
Long Term Debt = 1.90b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 1.25b EUR (from shortTermDebt, last quarter)
Debt = 5.55b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.94b EUR (from netDebt column, last quarter)
Enterprise Value = 29.82b EUR (25.91b + Debt 5.55b - CCE 1.64b)
Interest Coverage Ratio = 6.72 (Ebit TTM 2.09b / Interest Expense TTM 311.0m)
EV/FCF = 125.8x (Enterprise Value 29.82b / FCF TTM 237.0m)
FCF Yield = 0.79% (FCF TTM 237.0m / Enterprise Value 29.82b)
FCF Margin = 0.96% (FCF TTM 237.0m / Revenue TTM 24.81b)
Net Margin = 5.40% (Net Income TTM 1.34b / Revenue TTM 24.81b)
Gross Margin = 51.61% ((Revenue TTM 24.81b - Cost of Revenue TTM 12.01b) / Revenue TTM)
Gross Margin QoQ = 50.82% (prev 51.81%)
Tobins Q-Ratio = 1.47 (Enterprise Value 29.82b / Total Assets 20.26b)
Interest Expense / Debt = 1.57% (Interest Expense 87.0m / Debt 5.55b)
Taxrate = 12.50% (12.0m / 96.0m)
NOPAT = 1.83b (EBIT 2.09b * (1 - 12.50%))
Current Ratio = 1.32 (Total Current Assets 11.98b / Total Current Liabilities 9.09b)
Debt / Equity = 0.96 (Debt 5.55b / totalStockholderEquity, last quarter 5.78b)
Debt / EBITDA = 1.21 (Net Debt 3.94b / EBITDA 3.25b)
Debt / FCF = 16.61 (Net Debt 3.94b / FCF TTM 237.0m)
Total Stockholder Equity = 5.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.54% (Net Income 1.34b / Total Assets 20.26b)
RoE = 23.93% (Net Income TTM 1.34b / Total Stockholder Equity 5.60b)
RoCE = 27.89% (EBIT 2.09b / Capital Employed (Equity 5.60b + L.T.Debt 1.90b))
RoIC = 22.53% (NOPAT 1.83b / Invested Capital 8.12b)
WACC = 6.53% (E(25.91b)/V(31.46b) * Re(7.63%) + D(5.55b)/V(31.46b) * Rd(1.57%) * (1-Tc(0.12)))
Discount Rate = 7.63% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.03%
[DCF] Terminal Value 77.46% ; FCFF base≈1.09b ; Y1≈715.7m ; Y5≈326.5m
[DCF] Fair Price = 26.81 (EV 8.72b - Net Debt 3.94b = Equity 4.79b / Shares 178.5m; r=6.53% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 25.00 | EPS CAGR: -28.28% | SUE: -1.98 | # QB: 0
Revenue Correlation: 52.63 | Revenue CAGR: 3.70% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.31 | Chg7d=-0.513 | Chg30d=-0.513 | Revisions Net=-2 | Analysts=7
EPS current Year (2026-12-31): EPS=9.60 | Chg7d=-1.053 | Chg30d=-1.047 | Revisions Net=-2 | Growth EPS=+28.7% | Growth Revenue=+6.2%
EPS next Year (2027-12-31): EPS=12.04 | Chg7d=-0.527 | Chg30d=-0.578 | Revisions Net=-1 | Growth EPS=+22.9% | Growth Revenue=+9.0%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 7.9% - Earnings Yield 4.7%)
[Growth] Growth Spread = +3.6% (Analyst 6.9% - Implied 3.3%)